NFKB1 and chronic granulomatous disease: Based on this, this study integrated and designed an experiment that aimed to explore whether PPAR-γ could reduce inflammation and prevent gallstones by regulating the expression of NF-kB pathway and RAGE, to achieve the purpose of alleviating CGD, which is expected to provide potential targets and experimental evidence for the treatment of traditional Chinese medicine for CGD.